Grace Therapeutics, Inc. Number Of Outstanding Share Options
Grace Therapeutics, Inc. (GRCE) had Number Of Outstanding Share Options of 404667700.00% as of 2019-03-31, per its 20-F filed 2019-06-26.
Discontinued › Notes
ifrs-full:NumberOfOutstandingShareOptions · last filed 2019-06-26
- 2019-03-31: Number Of Outstanding Share Options 404667700.00%.
- 2018-03-31: Number Of Outstanding Share Options 228438800.00%.
- 2017-03-31: Number Of Outstanding Share Options 142478800.00%.
- 2017-02-28: Number Of Outstanding Share Options 142728800.00%.
| Period end | Number Of Outstanding Share Options |
|---|---|
| 2019-03-31 | 404667700.00% 20-F · filed 2019-06-26 |
| 2018-03-31 | 228438800.00% 20-F · filed 2019-06-26 |
| 2017-03-31 | 142478800.00% 20-F · filed 2019-06-26 |
| 2017-02-28 | 142728800.00% 20-F · filed 2019-06-26 |
| 2016-02-29 | 45415100.00% 20-F · filed 2019-06-26 |
| 2015-02-28 | 42962500.00% 20-F · filed 2018-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |